Mental Health

May 12th 2024

The survey reported that approximately 65% of participants were concerned about their mental health, which is a 15% increase since 2020.

May 8th 2024

This is the first FDA advisory committee meeting that will review a potential new posttraumatic stress disorder treatment in 25 years.

May 7th 2024

The story of gepirone may spark new conversations for industry standards on drug development to facilitate future innovations.

May 6th 2024

A new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.